To taper or not to taper? In this prospective study by Dr. Cho, #SLE patients in complete remission had a longer time to flare upon drug tapering vs. those in LLDAS or clinical remission states. #ACR22 @RheumNow ABST#0996 #ACRBEst @rheumarhyme https://t.co/bSGlkc7Tvk